HF
LEXX icon

HRT Financial’s Lexaria Bioscience LEXX Stock Holding History

HRT Financial’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
+18,465
New +$13.4K ﹤0.01% 3605
2024
Q4 		– Sell
-10,257
Closed -$31K – 2875
2024
Q3 		$31K Buy
+10,257
New +$32.6K ﹤0.01% 2154

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

HRT Financial's LEXX Position: Q1 2026 in Review

HRT Financial opened a new position in Lexaria Bioscience (LEXX) in Q1 2026: 18,465 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #3605 among its holdings. This is a return to the name: HRT Financial previously reported a position in LEXX as recently as Q3 2024.

HRT Financial first reported a position in LEXX in Q3 2024 and has held it in 2 quarters since. The position peaked at $31K in Q3 2024. 28 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • HRT Financial held 18,465 shares of Lexaria Bioscience worth $14K as of Q1 2026.
  • Lexaria Bioscience was a new HRT Financial position in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3605 holding.
  • HRT Financial first reported a position in Lexaria Bioscience in Q3 2024 and has held it in 2 quarters since.
  • HRT Financial's Lexaria Bioscience position peaked at $31K in Q3 2024.
  • 28 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.